In the BioHarmony Drug Report Database

"Preview" Icon

Darifenacin

Enablex, Emselex (darifenacin) is a small molecule pharmaceutical. Darifenacin was first approved as Enablex on 2004-10-22. It is used to treat overactive urinary bladder and urge urinary incontinence in the USA. It has been approved in Europe to treat overactive urinary bladder and urge urinary incontinence. The pharmaceutical is active against muscarinic acetylcholine receptor M3. In addition, it is known to target muscarinic acetylcholine receptor M1, muscarinic acetylcholine receptor M2, muscarinic acetylcholine receptor M5, and muscarinic acetylcholine receptor M4.

 

Trade Name

 

Emselex
 

Common Name

 

darifenacin
 

ChEMBL ID

 

CHEMBL1346
 

Indication

 

overactive urinary bladder, urge urinary incontinence
 

Drug Class

 

Muscarinic receptor antagonists

Image (chem structure or protein)

Darifenacin structure rendering